A Different Way to Think About Weight and Chronic Disease

If you have obesity, high blood pressure, and diabetes, you may be used to seeing three different specialists—one for each condition. New national guidelines suggest these conditions, along with kidney and cardiovascular disease, may be more connected than doctors previously thought, and that managing them together, rather than one at a time, could lead to better outcomes.

This cluster of conditions is called cardiovascular–kidney–metabolic (CKM) syndrome, and it’s changing how some doctors approach weight-related disease.

“It becomes a full-time job for patients to manage all this care,” says John Morton, MD, MPH, chief of Yale Medicine Bariatric and Minimally Invasive Surgery and a board-certified obesity medicine specialist.

In 2023, the American Heart Association (AHA) defined CKM syndrome, recognizing obesity, diabetes, kidney disease, and cardiovascular disease as interconnected conditions that often coexist and worsen one another. There wasn’t a comprehensive roadmap for how clinicians should treat CKM, though, until the AHA and the American College of Cardiology released the first treatment guideline for the condition.

CKM syndrome builds on the idea of metabolic syndrome—a cluster of risk factors that includes:

• Excess abdominal weight
• High blood pressure
• Elevated blood sugar
• Abnormal cholesterol

CKM syndrome expands that framework to include how those risk factors can affect organs such as the heart, kidneys, and liver over time.

“Think of CKM syndrome like metabolic syndrome plus kidney, plus liver,” explains Dr. Morton, who helped draft the new CKM guideline.

At the center of the new approach is a change in how doctors think about weight.

“For a long time, we’ve been treating the complications,” Dr. Morton says. “But we know there’s a root cause. Why not just treat the root cause?”

According to the guideline, excess weight—particularly when it contributes to inflammation in the body—plays a critical role in driving many related conditions. Over time, that process can affect blood sugar control, blood pressure, kidney function, and cardiovascular health.

“Weight and inflammation are what leads to heart failure, kidney failure, and all those things,” says Dr. Morton, who is also a professor of surgery at Yale School of Medicine.

This doesn’t mean weight is the only factor in someone’s health, or that having obesity makes those complications inevitable. The guideline isn’t about assigning blame—it treats excess weight as a measurable, treatable risk factor, similar to high cholesterol or high blood pressure. Addressing it early, the thinking goes, may help prevent more serious disease later.

One of the most important messages in the new guideline is the need to act before complications become severe.

“The idea is to work upstream instead of downstream,” Dr. Morton says. “A stitch in time saves nine.”

Instead of waiting until a patient develops advanced disease, clinicians are encouraged to identify and manage risk factors sooner—things like abdominal weight, elevated blood sugar, and early signs of kidney dysfunction.

The guideline also introduces a staging model, similar to what’s used in cancer care, to help clinicians see where a patient falls along the disease spectrum and tailor treatment accordingly.

“The sooner you treat, the better,” Dr. Morton says. “Early-stage disease is always easier to treat than late-stage disease.”

The guideline is written for clinicians, but patients may notice some changes in how care is delivered over time, such as:

• Your doctor asking about weight and metabolic health earlier, even before other symptoms appear
• More measurements being tracked, such as kidney function and waist circumference, to build a fuller picture of your risk
• A CKM “stage” being used to help guide when and how aggressively to treat

The ultimate hope, Dr. Morton says, is a more coordinated approach across specialties, potentially through dedicated CKM centers or care navigators that help patients reach the specialists they need through a single entry point.

Today, a person with obesity may also be managing diabetes, high blood pressure, sleep apnea, fatty liver disease, and early kidney disease—conditions that often mean visits with multiple specialists. A more integrated model aims to bring those disciplines together around the factors driving them.

At Yale, similar models are already in place. “That’s what our centers are like,” Dr. Morton says. “We try to get everybody under one roof.”

CKM remains a relatively new concept. But with backing from major organizations like the AHA, experts expect it to play a growing role in how chronic disease is managed.

“The model is really important,” Dr. Morton says. “It helps us understand that there’s a process—and that if we intervene earlier, we can change the outcome.”

If you have obesity along with conditions like high blood pressure, diabetes, or kidney disease, it may be worth asking your doctor whether they’re looking at your care through this more connected lens—and what steps could address the underlying drivers rather than just each condition on its own.